Northern Trust Corp Equillium, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Equillium, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 35,019 shares of EQ stock, worth $26,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,019
Previous 35,019
-0.0%
Holding current value
$26,964
Previous $29,000
6.9%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
0Put Options Held
0-
Decheng Capital LLC Menlo Park, CA4.45MShares$3.42 Million0.71% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$3.42 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$648,2990.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$432,954100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny261KShares$201,2780.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $26.5M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...